12-13-2009, 07:14 PM
Hi,
Since the etiology of the hypotension is likely due to SA node dysfunction, secondary to infarction in RCA territory. So, the goal of the treatment is to boost SA nodal activity.
Thus, I agree a trial of anti-cholinergic, and if not successful, pacing, would be reasonable. In addition, treating the MI itself with either PCI or thrombolytics is inherently important too.
drpanchet: Dobutamine is a beta1 agonist, is mainly used to increase contractility. Because hypotension was probably not due to an marked decrease in contractility, it should not be used b.c. it will adversely drive up the cardiac workload which is very undesirable for a ailing heart that is undersupplied with O2.
(ps. dobutamine, if it is doing anything to blood vessels, MIGHT dilate rather than constrict them since it is a beta-agonist; in fact, vessel constriction is not desirable in MI in general b.c. it will also incraese the cardiac work load).
Since the etiology of the hypotension is likely due to SA node dysfunction, secondary to infarction in RCA territory. So, the goal of the treatment is to boost SA nodal activity.
Thus, I agree a trial of anti-cholinergic, and if not successful, pacing, would be reasonable. In addition, treating the MI itself with either PCI or thrombolytics is inherently important too.
drpanchet: Dobutamine is a beta1 agonist, is mainly used to increase contractility. Because hypotension was probably not due to an marked decrease in contractility, it should not be used b.c. it will adversely drive up the cardiac workload which is very undesirable for a ailing heart that is undersupplied with O2.
(ps. dobutamine, if it is doing anything to blood vessels, MIGHT dilate rather than constrict them since it is a beta-agonist; in fact, vessel constriction is not desirable in MI in general b.c. it will also incraese the cardiac work load).